FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004109986> ?p ?o ?g. }

• W2004109986 endingPage "358" @default.
• W2004109986 startingPage "346" @default.
• W2004109986 abstract "<b><i>Background/Aims:</i></b> Ferric citrate hydrate (JTT-751) is being developed as a treatment for hyperphosphatemia in chronic kidney disease patients, and shows serum phosphorus-reducing effects on hyperphosphatemia in hemodialysis patients. We examined whether JTT-751 could reduce phosphorus absorption in normal rats and prevent the progression of ectopic calcification, secondary hyperparathyroidism and bone abnormalities in chronic renal failure (CRF) rats. <b><i>Methods:</i></b> Normal rats were fed a diet containing 0.3, 1 or 3% JTT-751 for 7 days. The effects of JTT-751 on phosphorus absorption were evaluated with fecal and urinary phosphorus excretion. Next, a CRF model simulating hyperphosphatemia was induced by feeding rats a 0.75% adenine diet. After 21 days of starting the adenine diet feeding, 1 or 3% JTT-751 was administered for 35 days by dietary admixture. The serum phosphorus levels and mineral parameters were measured. Calcification in the aorta was examined biochemically and histopathologically. Hyperparathyroidism and bone abnormalities were evaluated by histopathological analysis of the parathyroid and femur, respectively. <b><i>Results:</i></b> In normal rats, JTT-751 increased fecal phosphorus excretion and reduced phosphorus absorption and urinary phosphorus excretion. In CRF rats, JTT-751 reduced serum phosphorus levels, the calcium-phosphorus product and calcium content in the aorta. Serum intact parathyroid hormone levels and the incidence and severity of parathyroid hyperplasia were also decreased. JTT-751 reduced femoral bone fibrosis, porosity and osteoid formation. <b><i>Conclusions:</i></b> JTT-751 could bind with phosphate in the gastrointestinal tract, increase fecal phosphorus excretion and reduce phosphorus absorption. JTT-751 could prevent the progression of ectopic calcification, secondary hyperparathyroidism and bone abnormalities in rats." @default.
• W2004109986 created "2016-06-24" @default.
• W2004109986 creator A5001620097 @default.
• W2004109986 creator A5027463402 @default.
• W2004109986 creator A5028178383 @default.
• W2004109986 creator A5032991372 @default.
• W2004109986 creator A5041460034 @default.
• W2004109986 creator A5057516240 @default.
• W2004109986 creator A5071909206 @default.
• W2004109986 creator A5080701452 @default.
• W2004109986 creator A5082886327 @default.
• W2004109986 creator A5083811150 @default.
• W2004109986 date "2013-01-01" @default.
• W2004109986 modified "2023-10-18" @default.
• W2004109986 title "Ferric Citrate Hydrate, a New Phosphate Binder, Prevents the Complications of Secondary Hyperparathyroidism and Vascular Calcification" @default.
• W2004109986 cites W1496792713 @default.
• W2004109986 cites W1543423153 @default.
• W2004109986 cites W1981066436 @default.
• W2004109986 cites W1986900920 @default.
• W2004109986 cites W1988330339 @default.
• W2004109986 cites W2019991678 @default.
• W2004109986 cites W2035221187 @default.
• W2004109986 cites W2035726600 @default.
• W2004109986 cites W2043100243 @default.
• W2004109986 cites W2044593861 @default.
• W2004109986 cites W2045847718 @default.
• W2004109986 cites W2057994523 @default.
• W2004109986 cites W2058859173 @default.
• W2004109986 cites W2062571325 @default.
• W2004109986 cites W2069868276 @default.
• W2004109986 cites W2102964231 @default.
• W2004109986 cites W2103613742 @default.
• W2004109986 cites W2104306121 @default.
• W2004109986 cites W2114203325 @default.
• W2004109986 cites W2116223415 @default.
• W2004109986 cites W2119878754 @default.
• W2004109986 cites W2121615286 @default.
• W2004109986 cites W2123238413 @default.
• W2004109986 cites W2123897866 @default.
• W2004109986 cites W2124245235 @default.
• W2004109986 cites W2129279005 @default.
• W2004109986 cites W2140363010 @default.
• W2004109986 cites W2140411006 @default.
• W2004109986 cites W2147421976 @default.
• W2004109986 cites W2328568398 @default.
• W2004109986 doi "https://doi.org/10.1159/000348805" @default.
• W2004109986 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23548309" @default.
• W2004109986 hasPublicationYear "2013" @default.
• W2004109986 type Work @default.
• W2004109986 sameAs 2004109986 @default.
• W2004109986 citedByCount "50" @default.
• W2004109986 countsByYear W20041099862013 @default.
• W2004109986 countsByYear W20041099862014 @default.
• W2004109986 countsByYear W20041099862015 @default.
• W2004109986 countsByYear W20041099862016 @default.
• W2004109986 countsByYear W20041099862017 @default.
• W2004109986 countsByYear W20041099862018 @default.
• W2004109986 countsByYear W20041099862019 @default.
• W2004109986 countsByYear W20041099862020 @default.
• W2004109986 countsByYear W20041099862021 @default.
• W2004109986 countsByYear W20041099862022 @default.
• W2004109986 crossrefType "journal-article" @default.
• W2004109986 hasAuthorship W2004109986A5001620097 @default.
• W2004109986 hasAuthorship W2004109986A5027463402 @default.
• W2004109986 hasAuthorship W2004109986A5028178383 @default.
• W2004109986 hasAuthorship W2004109986A5032991372 @default.
• W2004109986 hasAuthorship W2004109986A5041460034 @default.
• W2004109986 hasAuthorship W2004109986A5057516240 @default.
• W2004109986 hasAuthorship W2004109986A5071909206 @default.
• W2004109986 hasAuthorship W2004109986A5080701452 @default.
• W2004109986 hasAuthorship W2004109986A5082886327 @default.
• W2004109986 hasAuthorship W2004109986A5083811150 @default.
• W2004109986 hasConcept C10146269 @default.
• W2004109986 hasConcept C126322002 @default.
• W2004109986 hasConcept C134018914 @default.
• W2004109986 hasConcept C178790620 @default.
• W2004109986 hasConcept C185592680 @default.
• W2004109986 hasConcept C2775945674 @default.
• W2004109986 hasConcept C2776036575 @default.
• W2004109986 hasConcept C2778838027 @default.
• W2004109986 hasConcept C2781208988 @default.
• W2004109986 hasConcept C510538283 @default.
• W2004109986 hasConcept C519063684 @default.
• W2004109986 hasConcept C71924100 @default.
• W2004109986 hasConceptScore W2004109986C10146269 @default.
• W2004109986 hasConceptScore W2004109986C126322002 @default.
• W2004109986 hasConceptScore W2004109986C134018914 @default.
• W2004109986 hasConceptScore W2004109986C178790620 @default.
• W2004109986 hasConceptScore W2004109986C185592680 @default.
• W2004109986 hasConceptScore W2004109986C2775945674 @default.
• W2004109986 hasConceptScore W2004109986C2776036575 @default.
• W2004109986 hasConceptScore W2004109986C2778838027 @default.
• W2004109986 hasConceptScore W2004109986C2781208988 @default.
• W2004109986 hasConceptScore W2004109986C510538283 @default.
• W2004109986 hasConceptScore W2004109986C519063684 @default.
• W2004109986 hasConceptScore W2004109986C71924100 @default.
• W2004109986 hasIssue "4" @default.
• W2004109986 hasLocation W20041099861 @default.

• next